Serum YKL-40 levels in patients with coronary artery disease

Coronary Artery Disease

Volumn 18, Issue 5, 2007, Pages 391-396

  Kucur, Mine ^a   Isman, Ferruh K ^b   Karadag, Bilgehan ^a   Vural, Vural A ^a   Tavsanoglu, Sedat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Atherosclerosis; Coronary artery disease; Inflammation; YKL 40

Indexed keywords

C REACTIVE PROTEIN; GLYCOPROTEIN GP 39;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; STENOSIS;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARTILAGE, ARTICULAR; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 34547531506     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328241d991     Document Type: Article

References (36)

1. Lusis AJ, Mar R, Pajukanta P. Genetics of atherosclerosis. Annu Rev Genomics Hum Genet 2004; 5:189-218.
2. Libby P. Inflammation in atherosclerosis. Nature 2002; 420:868-874.
3. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993; 268:25803-25810.
4. Renkema GH, Boot RG, Au FL, Donker-Koopman WE, Strijland A, Muijsers AO, et al. Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin is homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem 1998; 251:504-509.
5. Boot RG, van Achterberg TA, van Aken BE, Renkema GH, Jacobs MJ, Aerts JM, de Vries CJ. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 1999; 19:687-694.
6. Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005; 352:1685-1695.
7. Stary HC, Chandler B, Glagov S, Guyton JR, Insull WJr, Rosenfeld ME et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994; 89:2462-2478.
8. Danesh J, Muir J, Wong YK, Ward M, Gallimore JR, Pepys MB. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J 1999; 20:954-959.
9. Maresca G, Di Blasio A, Marchioli R, Di Minno G. Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arterioscler Thromb Vasc Biol 1999; 19:1368-1377.
10. Wildman RP, Muntner P, Chen J, Sutton-Tyrell K, He J. Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002. Am J Cardiol 2005; 96:1579-1583.
11. Azar RR, Aoun G, Fram DB, Waters DD, Wu AHB, Kiernan FJ. Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests. Am J Cardiol 2000; 86:205-207.
12. Hoffmeister A, Rothenbacher D, Bäzner U, Frönlich M, Brenner H, Hombach V, Koenig W. Role of novel markers of inflammation in patients with stable coronary heart disease. Am J Cardiol 2001; 87:262-266.
13. Taniguchi H, Momiyama Y, Ohmori R, Yonemura A, Yamashita T, Tamai S, et al. Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atherosclerosis 2005; 178:173-177.
14. Erren M, Reincke H, Junker R, Fobker M, Schulte H, Schurek JO, et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999; 19:2355-2363.
15. Krause SW, Rehli M, Kreutz M, Schwarzfischer L, Paulauskis JD, Andreesen R. Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol 1996; 60:540-546.
16. Rehli M, Krause SW, Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marher for late stages of macrophage differentiation. Genomics 1997; 43:221-225.
17. Young JL, Libby P, Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 2002; 88:554-567.
18. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 2002; 252:283-294.
19. Nieto FJ. Infections and atherosclerosis: new clues from and old hypothesis? Am J Epidemiol 1998; 148:937-948.
20. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135-1143.
21. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.
22. Artieda M, Cenarro A, Ganan A, Jerico I, Gonzalvo C, Casado JM, et al. Serum chitotriosidase activity increased in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol 2003; 23:1645-1652. Epub 2003 Jul 31.
23. Morrison BW, Leder P. Neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 1994; 9:3417-3426.
24. Harvey S, Weisman M, O'Dell J, Scott T, Krusemeier M, Visor J, Swindlehurst C. Chondrex: new marker of joint disease. Clin Chem 1998; 44:509-516.
25. Vind I, Johansen JS, Price PA, Munkholm P. Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease. Scand J Gastroenterol 2003; 38:599-605.
26. Johansen JS, Christoffersen P, Moller S, Price PA, Henriksen JH, Garbasch C, Bendtsen F. Serum YKL-40 is increased in patients with hepatic fibrosis. J Hepatol 2000; 32:911-920.
27. Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Ostergaard M, et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoartritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage 2001; 9:203-214.
28. Johansen JS, Olee T, Price PA, Hashimato S, Ochs RL, Lotz M. Regulation of YKL-40 production by human articular chondrocytes. Arthritis Rheum 2001; 44:826-837.
29. Johansen JS, Baslund B, Garbarsch C, Hansen M, Stoltenberg M, Lorenzen I, Price PA. YKL-40 in giant cells and macrophages from patients with giant cell arteritis. Arthritis Rheum 1999; 42:2624-2630.
30. Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, Wight TN. Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J Clin Invest 1995; 95:1158-1168.
31. Chajara A, Levesque H, Courel MN, Chauzy C, Maingonnat C, Bertrand P, et al. Hyaluronan and hyaluronectin production in injured rat thoracic aorta. Atherosclerosis 1996; 125:193-207.
32. Papakonstantinou E, Karakiulakis G, Roth M, Block LH. PDGF stimulates the secretion of hyaluronic acid by proliferating vascular smooth muscle cells. Proc Natl Acad Sci U S A 1995; 92:9881-9885.
33. Rehli M, Niller HH, Ammon C, Langmann S, Schwarzfischer L, Andreesen R, Krause SW. Transcriptional regulation of CH13L1, a marker gene for late stages of macrophage differentiation. J Biol Chem 2003; 278:44058-44067.
34. Arroyo-Espliguero R, Avanzas P, Cosin-Sales J, Aldama G, Pizzi C, Kaski JC. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 2004; 25:401-408.
35. Register TC, Carlson CS, Adams MR. Serum YKL-40 is associated with osteoarthritis and atherosclerosis in nonhuman primates. Clin Chem 2001; 47:2159-2161.
36. Rathcke CN, Johansen JS, Vestergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res 2006; 55:53-59.